SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Albiston AL, McDowall SG, Matsacos D, Sim P, Clune E, Mustafa T, Lee J, Mendelsohn FA, Simpson RJ, Connolly LM, Chai SY. 2001. Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. J Biol Chem 276: 4862348626.
  • Bernier SG, Fournier A, Guillemette G. 1994. A specific binding site recognizing a fragment adrenal cortex membranes. Eur J Pharmacol 271: 5563.
  • Braszko JJ, Kupryszewski G, Witczuk B, Wisniewski K. 1988. Angiotensin II (3-8)-hexapeptide affects motor activity, performance of passive avoidance and a conditioned response in rats. Neuroscience 27: 777783.
  • Caron AZ, Arguin G, Guillemette G. 2003. Angiotensin IV interacts with a juxtamembrane site on AT(4)/IRAP suggesting an allosteric mechanism of enzyme modulation. Regul Pept 113: 915.
  • Chen JK, Zimpelmann J, Harris RC, Burns KD. 2001. Angiotensin IV induces tyrosine phosphorylation of focal adhesion kinase and paxillin in proximal tubule cells. Am J Physiol Renal Physiol 280: F980F988.
  • Coleman JKM, Krebs LT, Ong B, Hanesworth JM, Lawrence KA, Sardinia M, Harding JW, Wright JW. 1993. Changes in renal blood flow due to intra-arterial infusions of angiotensin II (3-8) [AngIV] and AngIV analogues. FASEB J 7: A437.
  • de Gasparo M, Husain A, Alexander W, Catt KJ, Chiu AT, Drew M, Goodfriend T, Harding JW, Inagami T, Timmermans PBMWM. 1995. Proposed update of angiotensin nomenclature. Hypertension 25: 924927.
  • DeLean A, Ong H, Gutkowska J, Schiller PW, McNicoll N. 1984. Evidence for agonist-induced interaction of angiotensin receptor with guanine nucleotide-binding protein in bovine adrenal zona glomerulosa. Mol Pharmacol 26: 498508.
  • Ferguson AV, Wall KM. 1992. Central actions of angiotensin in cardiovascular control: multiple roles for a single peptide. Can J Physiol Pharmacol 70: 779785.
  • Glossman H, Baukal A, Catt KJ. 1974. Angiotensin II receptors in bovine adrenal cortex: modification of angiotensin II binding quanyl nucleotides. J Biol Chem 249: 664666.
  • Haberl RL, Decker PJ, Einhäupl KM. 1991. Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles. Circ Res 68: 16211627.
  • Hall KL, Hanesworth JM, Ball AE, Felgenhauer GP, Hosick LL, Harding JW. 1993. Identification and characterization of a novel angiotensin binding site in cultured vascular smooth muscle cells that is specific for the hexapeptide (3-8) fragment of angiotensin II, angiotesin IV. Regul Pept 44: 225232.
  • Hall KL, Venkateswaren S, Hanesworth JM, Schelling ME, Harding JW. 1995. Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells. Regul Pept 58: 107115.
  • Hamilton TA, Handa RK, Harding JW, Wright JW. 2001. A role for the angiotensin IV/AT4 system in mediating natriuresis in the rat. Peptides 22: 935944.
  • Hanesworth JM, Sardinia MF, Krebs LT, Hall KL, Harding JW. 1993. Elucidation of a specific binding site for angiotensin II (3-8), angiotensin IV, in the mammalian heart membranes. J Pharmacol Exp Ther 266: 10361042.
  • Handa RK, Harding JW, Handa SE. 1996. Inhibition of proximal tubule Na+ transport by angiotensin: role of the AT4 receptor. FASEB J 10: A396.
  • Harding JW, Cook VI, Miller-Wing AV, Hanesworth JW, Sardinia MF, Hall JL, Stobb JW, Swanson GN, Coleman JK, Wright JW, Harding EC. 1992. Identification of an AngII (3-8) [AngIV] binding site in guinea pig hippocampus. Brain Res 583: 340343.
  • Herbst JJ, Ross SA, Scott HM, Bobin SA, Morris NJ, Lienhard GE, Keller SR. 1997. Insulin stimulates cell surface aminopeptidase activity toward vasopressin in adipocytes. Am J Physiol 272(4 Pt 1): E600-E606.
  • Kandror KV, Yu L, Pilch PF. 1994. The major protein of GLUT4-containing vesicles, gp160, has aminopeptidase activity. J Biol Chem 269: 3077730780.
  • Kerins DM, Hao Q, Vaughan DE. 1995. Angiotensin induction of PAI-1 expression in endothelial cells mediated by the hexapeptide angiotensin IV. J Clin Invest 96: 25152520.
  • Kramár EA, Harding JW, Wright JW. 1997. Angioteinsin II- and IV-induced changes in cerebral blood flow: roles of AT1, AT2, and AT4 receptor subtypes. Regul Pept 68: 131138.
  • Kramár EA, Armstrong DL, Ikeda S, Wayner MJ, Harding JW, Wright JW. 2001. The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro. Brain Res 897: 114121.
  • Krebs LK, Kramár EA, Hanesworth JM, Sardinia MF, Ball AE, Wright JW, Harding JW. 1996. Characterization of the binding properties and physiological action of divenal-angiotensin IV, a putative receptor antagonist. Regul Pept 67: 123130.
  • Larson WJ. 1993. Development of the urogenital system. In: SchmidtWR, OtwayM, Bowman-SchulmanE, editors. Human embryology. New York: Churchill Livingstone. p 235245.
  • Lee J, Mustafa T, McDowall SG, Mendelsohn FA, Brennan M, Lew RA, Albiston AL, Chai SY. 2003. Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase. J Pharmacol Exp Ther 305: 205211.
  • Li YD, Block ER, Patel JM. 2002. Activation of multiple signaling modules is critical in angiotensin IV-induced lung endothelial cell proliferation. Am J Physiol Lung Cell Mol Physiol 283: L707L716.
  • Miller-Wing AV, Hanesworth JM, Sardinia MF, Wright JW, Speth RC, Grove KL, Harding JW. 1993. Central angiotensin IV receptors: distribution and specificity in guinea pig brain. J Pharmacol Exp Ther 266: 17181726.
  • Moeller I, Chai SY, Oldfield BJ, McKinley MJ, Casley D, Mendelsohn FAO. 1995. Localization of angiotensin IV binding sites to motor and sensory neurons in the sheep spinal cord and hindbrain. Brain Res 701: 301306.
  • Moeller I, Paxinos G, Mendelsohn FAO, Aldred GP, Casley D, Chai SY. 1996a. Distribution of AT4 receptors in the macaca fascicularis brain. Brain Res 712: 307324.
  • Moeller I, Paxinos G, Small DH, Reed DH, Harding JW, Mendelsohn FAO, Chai SY. 1996b. Angiotensin IV inhibits neurite outgrowth in cultured embryonic chicken sympathetic neurons. Brain Res 725: 6166.
  • Näveri L, Strömberg C, Saavedra JM. 1994. Angiotensin IV reverses the acute cerebral blood flow reduction after experimental subarachnoid hemorrhage in the rat. J Cereb Blood Flow Metabol 14: 10961099.
  • Pendleton RG, Gessner G, Horner E. 1989. Studies defining minimal receptor domains for angiotensin II. J Pharmacol Exp Ther 250: 3136.
  • Phillips MI. 1987. Functions of angiotensin in the central nervous system. Ann Rev Physiol 49: 413435.
  • Ross SA, Scott HM, Morris NJ, Leung WY, Mao F, Lienhard GE, Keller SR. 1996. Characterization of the insulin-regulated membrane aminopeptidase in 3T3-L1 adipocytes. J Biol Chem 271: 33283332.
  • Sardinia MF, Hanesworth JM, Krebs LT, Harding JW. 1993. AT4 receptor binding characteristics: d-amino acid and glycine-substituted peptides. Peptides 14: 949954.
  • Sardinia MF, Hanesworth JM, Krishnan F, Harding JW. 1994. AT4 receptor structure-binding relationship: N-terminal-modified angiotensin IV analogues. Peptides 15: 13991406.
  • Swanson GN, Hanesworth JM, Sardinia MF, Coleman JKM, Wright JW, Hall KL, Miller-Wing AV, Stobb JW, Cook VI, Harding EC, Harding JW. 1992. Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor. Regul Pept 40: 409419.
  • Tonnaer JADM, Weigant VM, DeJong W, DeWeid D. 1982. Central effects of angiotensin on drinking and blood pressure: structure-activity relationships. Brain Res 236: 417428.
  • Wright JW, Miller-Wing AV, Shaffer MJ, Higginson C, Wright DE, Hanesworth JM, Harding JW. 1993. Angiotensin II(3-8) (AngIV) hippocampal binding: potential role in the facilitation of memory. Brain Res Bull 32: 497502.
  • Wright JW, Krebs LT, Stobb JW, Harding JW. 1995. The angiotensin IV system: functional implications. Front Neuroendocrinol 16: 2352.